Currently Skimming:
Appendix B: Speaker Biographical Sketches
Appendix B: Speaker Biographical Sketches
Pages 67-78
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 67... ...
His specific areas of expertise are skeletal diseases and the biology and clinical use of skeletal stem cells (also known as mesenchymal stem cells)
|
From page 68... ...
He is a health senior scholar with the Alberta Heritage Foundation for Medical Research and the principal investigator for a number of large interdisciplinary projects that explore the ethical, legal, and health policy issues associated with a range of topics, including stem cell research, genetics, patient safety, the prevention of chronic disease, obesity policy, the commercialization of research, complementary and alternative medicine, and access to health care. Professor Caulfield is and has been involved with a number of national and international policy and research ethics committees, including the Canadian Biotechnology Advisory Committee, Genome Canada's Science Advisory Committee, the Ethics and Public Policy Committee for International Society for Stem Cell Research (ISSCR)
|
From page 69... ...
; "Ethical Issues in Human Stem Cell Research" (1999) ; "Ethical and Policy Issues in International Research: Clinical Trials in Developing Countries" (2001)
|
From page 70... ...
From Seoul to Krakow to Vancouver, Professor Cohen has spoken at legal, medical, and industry conferences around the world and his work has been covered on PBS, National Public Radio, ABC, Mother Jones, The New York Times, The Boston Globe, and several other media venues. Professor Cohen's current projects relate to reproduction/reproductive technology, research ethics, rationing in law and medicine, health policy, and to medical tourism -- the travel of patients who are residents of one country, the "home country," to another country, the "destination country," for medical treatment.
|
From page 71... ...
Important research contributions from his laboratory include the creation of customized stem cells to treat genetic immune deficiency in a mouse model (together with Rudolf Jaenisch) , the differentiation of germ cells from embryonic stem cells (cited as a Top Ten Breakthrough by Science magazine in 2003)
|
From page 72... ...
Mead Johnson Award from the American Pediatric Society for contributions to stem cell research, and the E Donnall Thomas Prize of the American Society for Hematology for advances in human induced pluripotent stem cells.
|
From page 73... ...
, as chairman of the Health Care Technology Study Section of the National Center for Health Services Research (1982-1985) , and as president of the Association of Schools of Public Health (1995-1996)
|
From page 74... ...
PAN serves as the voice of Parkinson's on numerous public policy issues affecting the Parkinson's community. In addition to continuing its work on NIH funding and research, the Parkinson's community is now a powerful voice on many crucial issues including Parkinson's specific programs at the Departments of Defense and Veteran's Affairs and the Department of Health and Human Services, FDA drug approval issues, and the continuing
|
From page 75... ...
She has testified before several congressional committees and subcommittees and in 2011 was honored as an Innovator by the Genetic Alliance for her work on the complex federal embryonic stem cell research policy. Prior to joining PAN, she served as the Senate-confirmed director of the U.S.
|
From page 76... ...
Doug Sipp, B.A., is head of the Science Policy and Ethics Studies unit at the RIKEN Center for Developmental Biology in Kobe, Japan. His work focuses primarily on issues in the clinical application and commercialization of stem cell therapeutics, and the analysis of approaches to stem cell research and development in the Asia-Pacific region.
|
From page 77... ...
Before joining the faculty of the Georgetown University Law Center, Vladeck spent nearly 30 years as a lawyer at the Public Citizen Litigation Group, the litigation arm of Public Citizen, an advocacy organization founded by Ralph Nader. He served as the group's director for 10 years.
|
From page 78... ...
Professor Zhou studies the mechanisms of reprogramming, differentiation, and de-differentiation as well as cellular plasticity and totipotency of stem cells and somatic cells, with the goal of understanding the mechanisms of mammalian cloning and improving cloning efficiency as well as promoting the application of stem cells in regenerative medicine.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.